Fig. 2
Kaplan Meir curve for PFS among 4 groups. Blue-dose >50gy+concomittent Bevacizumab. Red-dose>50gy alone. Light green-dose<50gy + concomittent bevacizumab. Purple-dose>50Gy
Fig. 2 | Radiation Oncology
Kaplan Meir curve for PFS among 4 groups. Blue-dose >50gy+concomittent Bevacizumab. Red-dose>50gy alone. Light green-dose<50gy + concomittent bevacizumab. Purple-dose>50Gy